Marc Radke

6PUBLICATIONS
59CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 27, 2026
HRDetect in Tubo-ovarian Carcinoma: Stratification and Therapeutic Implications.

|Jun 21, 2023
BLM overexpression as a predictive biomarker for CHK1 inhibitor response in PARP inhibitor-resistant BRCA-mutant ovarian cancer.

Nitasha Gupta, Tzu-Ting Huang, Jayakumar R Nair

|May 17, 2023
Diagnosis of Ovarian Carcinoma Homologous Recombination DNA Repair Deficiency From Targeted Gene Capture Oncology Assays.

Niklas Krumm, Nithisha S Khasnavis, Marc Radke

|Oct 18, 2022
Randomized Trial of Olaparib With or Without Cediranib for Metastatic Castration-Resistant Prostate Cancer: The Results From National Cancer Institute 9984.

Joseph W Kim, Rana R McKay, Marc R Radke

|Apr 09, 2021
Long-term survival of an ovarian cancer patient harboring a RAD51C missense mutation.

Meghan R Sullivan, Rohit Prakash, Yashpal Rawal

Pageof 1